Regeneron Pharmaceuticals Inc (REGN) Q4 2022 Earnings Call Transcript
[ad_1] Regeneron Pharmaceuticals Inc (NASDAQ: REGN) Q4 2022 earnings call dated Feb. 03, 2023 Corporate Participants: Ryan Crowe — Vice President, Investor Relations Leonard S. Schleifer — Co-Founder, President and Chief Executive Officer George D. Yancopoulos — Co-Founder, President and Chief Scientific Officer Marion McCourt — Executive Vice…




